110 related articles for article (PubMed ID: 15185387)
1. How property rights and patents affect antibiotic resistance.
Horowitz JB; Moehring HB
Health Econ; 2004 Jun; 13(6):575-83. PubMed ID: 15185387
[TBL] [Abstract][Full Text] [Related]
2. The information revolution reaches pharmaceuticals: balancing innovation incentives, cost, and access in the post-genomics era.
Rai AK
Univ Ill Law Rev; 2001; 2001(1):173-210. PubMed ID: 16493845
[TBL] [Abstract][Full Text] [Related]
3. Societal costs versus savings from wild-card patent extension legislation to spur critically needed antibiotic development.
Spellberg B; Miller LG; Kuo MN; Bradley J; Scheld WM; Edwards JE
Infection; 2007 Jun; 35(3):167-74. PubMed ID: 17565458
[TBL] [Abstract][Full Text] [Related]
4. [Patents in pharmaceutical industry: between ethics and property rights].
Martínez Cárdenas EE
Rev Salud Publica (Bogota); 2003; 5(1):18-23. PubMed ID: 14658364
[TBL] [Abstract][Full Text] [Related]
5. Patent law--balancing profit maximization and public access to technology.
Beckerman-Rodau A
Columbia Sci Technol Law Rev; 2003; 4():E1. PubMed ID: 15977333
[TBL] [Abstract][Full Text] [Related]
6. Patents for critical pharmaceuticals: the AZT case.
Ackiron E
Am J Law Med; 1991; 17(1-2):145-80. PubMed ID: 1877607
[TBL] [Abstract][Full Text] [Related]
7. [Antibiotic resistance--bacteria fight back].
Tambić Andrasević A
Acta Med Croatica; 2004; 58(4):245-50. PubMed ID: 15700679
[TBL] [Abstract][Full Text] [Related]
8. Patenting nanotechnology.
Lemley MA
Stanford Law Rev; 2005 Nov; 58(2):601-30. PubMed ID: 16395838
[TBL] [Abstract][Full Text] [Related]
9. Disability benefit coverage and program interactions in the working-age population.
Rupp K; Davies PS; Strand A
Soc Secur Bull; 2008; 68(1):1-30. PubMed ID: 18837269
[TBL] [Abstract][Full Text] [Related]
10. Optimal use of antibiotic resistance surveillance systems.
Critchley IA; Karlowsky JA
Clin Microbiol Infect; 2004 Jun; 10(6):502-11. PubMed ID: 15191377
[TBL] [Abstract][Full Text] [Related]
11. Economics of antibiotic resistance.
Sipahi OR
Expert Rev Anti Infect Ther; 2008 Aug; 6(4):523-39. PubMed ID: 18662118
[TBL] [Abstract][Full Text] [Related]
12. How does the persistence of depression influence the continuity and type of health insurance and coverage limits on mental health therapy?
Masaquel A; Wells K; Ettner SL
J Ment Health Policy Econ; 2007 Sep; 10(3):133-44. PubMed ID: 17890830
[TBL] [Abstract][Full Text] [Related]
13. Monopoly pricing of an antibiotic subject to bacterial resistance.
Herrmann M
J Health Econ; 2010 Jan; 29(1):137-50. PubMed ID: 20015559
[TBL] [Abstract][Full Text] [Related]
14. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
[TBL] [Abstract][Full Text] [Related]
15. Resistance-induced antibiotic substitution.
Howard DH
Health Econ; 2004 Jun; 13(6):585-95. PubMed ID: 15185388
[TBL] [Abstract][Full Text] [Related]
16. Causal regulations vs. political will: why human zoonotic infections increase despite precautionary bans on animal antibiotics.
Cox LA; Ricci PF
Environ Int; 2008 May; 34(4):459-75. PubMed ID: 18201762
[TBL] [Abstract][Full Text] [Related]
17. Pricing and reimbursement of pharmaceuticals in Italy.
Folino-Gallo P; Montilla S; Bruzzone M; Martini N
Eur J Health Econ; 2008 Aug; 9(3):305-10. PubMed ID: 18566845
[TBL] [Abstract][Full Text] [Related]
18. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
Führlinger S
Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
[TBL] [Abstract][Full Text] [Related]
19. Reducing antimicrobial resistance through appropriate antibiotic usage in Singapore.
Hsu LY; Kwa AL; Lye DC; Chlebicki MP; Tan TY; Ling ML; Wong SY; Goh LG
Singapore Med J; 2008 Oct; 49(10):749-55. PubMed ID: 18946605
[TBL] [Abstract][Full Text] [Related]
20. National hospital antibiotic timing measures for pneumonia and antibiotic overuse.
Drake DE; Cohen A; Cohn J
Qual Manag Health Care; 2007; 16(2):113-22. PubMed ID: 17426609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
